Search - tctmd.com

Displaying 281 - 300 of 585

Sort: Relevancy | Date

Complete 2-Year Data From Evolut Low-Risk Trial ‘Reassuring’ for TAVI

News Conference News EuroPCR 2021

Complete 2-Year Data From Evolut Low-Risk Trial ‘Reassuring’ for TAVI

Yael L. Maxwell

May 19, 2021

Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC

News Conference News ACC 2021

Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC

Michael O'Riordan

May 17, 2021

Low 1-Year Stroke Risk After Commercial Watchman Use

News Conference News ACC 2021

Low 1-Year Stroke Risk After Commercial Watchman Use

May 15, 2021

ATLANTIS: Apixaban Has No Benefit Over Standard of Care Post-TAVI

News Conference News ACC 2021

ATLANTIS: Apixaban Has No Benefit Over Standard of Care Post-TAVI

Yael L. Maxwell

May 15, 2021

Occluding the LAA During Surgery Lowers Stroke Risk: LAAOS III

News Conference News ACC 2021

Occluding the LAA During Surgery Lowers Stroke Risk: LAAOS III

May 15, 2021

Wide Variation in TAVI Readmission Rates Among US Hospitals

News Conference News ACC 2021

Wide Variation in TAVI Readmission Rates Among US Hospitals

May 07, 2021

Harmony TPV Continues to Reduce Pulmonary Valve Regurgitation at 1 Year

News Conference News SCAI 2021

Harmony TPV Continues to Reduce Pulmonary Valve Regurgitation at 1 Year

Yael L. Maxwell

May 04, 2021

As Market Forces Drive TAVI Access, Rural Patients Left Behind

News Conference News SCAI 2021

As Market Forces Drive TAVI Access, Rural Patients Left Behind

Michael O'Riordan

April 29, 2021

Low Mortality and Stroke Rates With BASILICA Pre-TAVI, Registry Shows

News Conference News CRT 2021

Low Mortality and Stroke Rates With BASILICA Pre-TAVI, Registry Shows

Michael O'Riordan

March 09, 2021

DOAC Use Increasing in Patients With Bioprosthetic Heart Valves

News Conference News CRT 2021

DOAC Use Increasing in Patients With Bioprosthetic Heart Valves

March 08, 2021

No Angina? No Benefit to PCI Pre-TAVR: ACTIVATION

News Conference News PCR London Valves 2020

No Angina? No Benefit to PCI Pre-TAVR: ACTIVATION

November 26, 2020

Next-Gen MitraClip Performs as Well as Earlier Device in COAPT: EXPAND

News Conference News PCR London Valves 2020

Next-Gen MitraClip Performs as Well as Earlier Device in COAPT: EXPAND

Michael O'Riordan

November 25, 2020

CUTTING-EDGE Insights into MV Surgery Outcomes After Failed Clip Procedures

News Conference News PCR London Valves 2020

CUTTING-EDGE Insights into MV Surgery Outcomes After Failed Clip Procedures

November 24, 2020

Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib

News Conference News AHA 2020

Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib

November 14, 2020

Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up

News Conference News TCT 2020

Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up

Michael O'Riordan

October 23, 2020

While Rare, Surgical Removal of TAVR Carries Risks: Global EXPLANT-TAVR Registry

News Conference News TCT 2020

While Rare, Surgical Removal of TAVR Carries Risks: Global EXPLANT-TAVR Registry

October 21, 2020

MitraClip Viable in MI Patients With Acute MR, Including Patients in Shock: IREMMI

News Conference News TCT 2020

MitraClip Viable in MI Patients With Acute MR, Including Patients in Shock: IREMMI

Michael O'Riordan

October 17, 2020

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

News Conference News TCT 2020

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

October 17, 2020

MitraBridge: Could a MitraClip Help Patients Avoid Heart Transplant?

News Conference News TCT 2020

MitraBridge: Could a MitraClip Help Patients Avoid Heart Transplant?

October 16, 2020

Global EXPAND: Next-Gen MitraClip Cuts MR, Boosts QoL at 1 Year

News Conference News TCT 2020

Global EXPAND: Next-Gen MitraClip Cuts MR, Boosts QoL at 1 Year

October 16, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.